We herein present the first left atrial appendage (LAA) percutaneous closure procedure performed in our Institution with use of the Watchman device in an 82-year old woman with atrial fibrillation, unable to continue receiving anticoagulation therapy due to bleeding complications. A propos with this case, we discuss the data related to this therapeutic approach geared to prevent thromboembolism in patients with atrial fibrillation and contraindications to treatment with anticoagulants
Left atrial appendage (LAA) occlusion is a potential alternative to warfarin in patients with atrial...
Atrial fibrillation is a frequent cause of stroke; in the elderly, more than 20% of strokes are attr...
Introduction. In the setting of atrial fibrillation (AF), left atrial appendage (LAA) closure using ...
We herein present the first left atrial appendage (LAA) percutaneous closure procedure performed in ...
Abstract: Background: Atrial fibrillation (AF) is the most commonly encountered clinical arrhythmia,...
ABSTRACTBackgroundStroke secondary to atrial fibrillation has been associated to a high risk of perm...
Background/ObjectiveAtrial fibrillation (AF) is the most common sustained cardiac arrhythmia. It is ...
Background: Percutaneous left atrial appendage closure (LAAC) with WATCHMAN (WM) has been recognized...
ObjectivesThis study assessed the feasibility of implanting a device in the left atrial appendage (L...
Background. Left atrial appendage (LAA) closure represents an alternative strategy to oral anticoagu...
AbstractBackgroundAtrial fibrillation (AF) is considered the major cause of stroke in the elderly. A...
BACKGROUND Left atrial appendage (LAA) occlusion with WATCHMAN has emerged as viable alternative to ...
ABSTRACT: Atrial fibrillation is the most common arrhythmia found in clinical practice, with a popul...
Aims Left atrial appendage closure is a non-pharmacological alternative for stroke prevention in hig...
International audienceLeft atrial appendage (LAA) closure using the WATCHMAN™ device (WM) may be con...
Left atrial appendage (LAA) occlusion is a potential alternative to warfarin in patients with atrial...
Atrial fibrillation is a frequent cause of stroke; in the elderly, more than 20% of strokes are attr...
Introduction. In the setting of atrial fibrillation (AF), left atrial appendage (LAA) closure using ...
We herein present the first left atrial appendage (LAA) percutaneous closure procedure performed in ...
Abstract: Background: Atrial fibrillation (AF) is the most commonly encountered clinical arrhythmia,...
ABSTRACTBackgroundStroke secondary to atrial fibrillation has been associated to a high risk of perm...
Background/ObjectiveAtrial fibrillation (AF) is the most common sustained cardiac arrhythmia. It is ...
Background: Percutaneous left atrial appendage closure (LAAC) with WATCHMAN (WM) has been recognized...
ObjectivesThis study assessed the feasibility of implanting a device in the left atrial appendage (L...
Background. Left atrial appendage (LAA) closure represents an alternative strategy to oral anticoagu...
AbstractBackgroundAtrial fibrillation (AF) is considered the major cause of stroke in the elderly. A...
BACKGROUND Left atrial appendage (LAA) occlusion with WATCHMAN has emerged as viable alternative to ...
ABSTRACT: Atrial fibrillation is the most common arrhythmia found in clinical practice, with a popul...
Aims Left atrial appendage closure is a non-pharmacological alternative for stroke prevention in hig...
International audienceLeft atrial appendage (LAA) closure using the WATCHMAN™ device (WM) may be con...
Left atrial appendage (LAA) occlusion is a potential alternative to warfarin in patients with atrial...
Atrial fibrillation is a frequent cause of stroke; in the elderly, more than 20% of strokes are attr...
Introduction. In the setting of atrial fibrillation (AF), left atrial appendage (LAA) closure using ...